CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC)
- Citation:
- J Clin Oncol vol 30 (suppl) abstr 7513
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2046
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. C. Suk Heist X. Wang L. D. Hodgson G. A. Otterson T. E. Stinchcombe M. A. Socinski
- Networks:
- Study
- CALGB-30704
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: